Viewing Study NCT05175235


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2025-12-28 @ 9:35 PM
Study NCT ID: NCT05175235
Status: UNKNOWN
Last Update Posted: 2023-03-03
First Post: 2021-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
Sponsor: National University Hospital, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module